Stifel Financial’s Thermo Fisher Scientific TMO Stock Holding History

Stifel Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$319M	Sell	649,147 -31,866	-5%	-$17.3M	0.29%	76
2025 Q4	$395M	Buy	681,013 +6,865	+1%	+$3.88M	0.36%	57
2025 Q3	$327M	Sell	674,148 -9,073	-1%	-$4.22M	0.3%	71
2025 Q2	$277M	Buy	683,221 +17,713	+3%	+$7.41M	0.27%	80
2025 Q1	$331M	Buy	665,508 +8,412	+1%	+$4.56M	0.35%	70
2024 Q4	$342M	Sell	657,096 -9,881	-1%	-$5.43M	0.36%	68
2024 Q3	$413M	Buy	666,977 +6,997	+1%	+$4.14M	0.43%	56
2024 Q2	$365M	Buy	659,980 +2,238	+0.3%	+$1.28M	0.41%	59
2024 Q1	$382M	Sell	657,742 -5,467	-0.8%	-$3.07M	0.44%	56
2023 Q4	$352M	Sell	663,209 -3,777	-0.6%	-$1.83M	0.44%	55
2023 Q3	$338M	Buy	666,986 +39,328	+6%	+$21M	0.47%	53
2023 Q2	$327M	Buy	627,658 +3,247	+0.5%	+$1.75M	0.45%	55
2023 Q1	$360M	Sell	624,411 -87,056	-12%	-$49.1M	0.52%	46
2022 Q4	$392M	Sell	711,467 -7,974	-1%	-$4.23M	0.59%	35
2022 Q3	$365M	Buy	719,441 +9,717	+1%	+$5.44M	0.6%	35
2022 Q2	$386M	Buy	709,724 +22,702	+3%	+$12.5M	0.6%	31
2022 Q1	$406M	Sell	687,022 -1,393	-0.2%	-$800K	0.55%	35
2021 Q4	$459M	Buy	688,415 +9,123	+1%	+$5.7M	0.61%	28
2021 Q3	$388M	Sell	679,292 -114	-0%	-$62.6K	0.57%	36
2021 Q2	$343M	Buy	679,406 +21,357	+3%	+$10.1M	0.51%	44
2021 Q1	$300M	Sell	658,049 -26,334	-4%	-$12.6M	0.5%	46
2020 Q4	$319M	Buy	684,383 +11,678	+2%	+$5.48M	0.57%	35
2020 Q3	$297M	Buy	672,705 +40,772	+6%	+$16.8M	0.61%	34
2020 Q2	$229M	Buy	631,933 +10,336	+2%	+$3.46M	0.53%	41
2020 Q1	$176M	Sell	621,597 -136,872	-18%	-$43.2M	0.49%	52
2019 Q4	$247M	Buy	758,469 +94,706	+14%	+$28.7M	0.51%	40
2019 Q3	$193M	Sell	663,763 -2,909	-0.4%	-$833K	0.49%	36
2019 Q2	$196M	Buy	666,672 +97,269	+17%	+$26.8M	0.5%	38
2019 Q1	$156M	Sell	569,403 -4,437	-0.8%	-$1.1M	0.44%	47
2018 Q4	$128M	Sell	573,840 -2,048	-0.4%	-$481K	0.42%	47
2018 Q3	$140M	Buy	575,888 +4,636	+0.8%	+$1.07M	0.4%	52
2018 Q2	$118M	Buy	571,252 +1,570	+0.3%	+$333K	0.36%	60
2018 Q1	$118M	Sell	569,682 -1,565	-0.3%	-$328K	0.37%	61
2017 Q4	$108M	Buy	571,247 +13,215	+2%	+$2.53M	0.34%	67
2017 Q3	$106M	Buy	558,032 +12,297	+2%	+$2.23M	0.37%	57
2017 Q2	$95.2M	Sell	545,735 -14,992	-3%	-$2.52M	0.35%	63
2017 Q1	$86.1M	Buy	560,727 +23,191	+4%	+$3.54M	0.33%	68
2016 Q4	$75.9M	Buy	537,536 +2,932	+0.5%	+$432K	0.32%	69
2016 Q3	$85M	Sell	534,604 -27,730	-5%	-$4.27M	0.38%	56
2016 Q2	$83.1M	Buy	562,334 +13,158	+2%	+$1.94M	0.38%	60
2016 Q1	$77.8M	Buy	549,176 +63,572	+13%	+$8.52M	0.41%	54
2015 Q4	$68.9M	Sell	485,604 -27,525	-5%	-$3.67M	0.36%	64
2015 Q3	$62.7M	Buy	513,129 +17,798	+4%	+$2.32M	0.35%	66
2015 Q2	$64.2M	Buy	495,331 +22,989	+5%	+$3M	0.33%	66
2015 Q1	$63.4M	Sell	472,342 -32,501	-6%	-$4.19M	0.35%	56
2014 Q4	$63.3M	Buy	504,843 +362,542	+255%	+$44.1M	0.35%	53
2014 Q3	$17.3M	Buy	142,301 +54,354	+62%	+$6.61M	0.15%	163
2014 Q2	$10.4M	Buy	87,947 +14,879	+20%	+$1.75M	0.09%	276
2014 Q1	$8.79M	Buy	+73,068	New	+$8.69M	0.08%	303

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stifel Financial's TMO Position: Q1 2026 in Review

Stifel Financial reduced its Thermo Fisher Scientific (TMO) stake by 4.7% in Q1 2026, selling an estimated $17.3M and leaving 649,147 shares worth $319M. The position accounts for 0.29% of the portfolio, ranked #76.

Stifel Financial first reported a position in TMO in Q1 2014 and has held it in 49 quarters since. The position peaked at $459M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Stifel Financial held 649,147 shares of Thermo Fisher Scientific worth $319M as of Q1 2026.
Stifel Financial sold 31,866 Thermo Fisher Scientific shares in Q1 2026, an estimated $17.3M.
Thermo Fisher Scientific made up 0.29% of Stifel Financial's portfolio in Q1 2026, its #76 holding.
Stifel Financial first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 49 quarters since.
Stifel Financial's Thermo Fisher Scientific position peaked at $459M in Q4 2021.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.